Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.63 |
| ▸ | CA1 | P00915 | 10/20 | 0.63 |
| ▸ | CA12 | O43570 | 10/20 | 0.63 |
| ▸ | CA9 | Q16790 | 10/20 | 0.63 |
| ▸ | CA4 | P22748 | 8/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 8/20 | 0.63 |
| ▸ | CA5A | P35218 | 8/20 | 0.63 |
| ▸ | CA6 | P23280 | 7/20 | 0.63 |
| ▸ | CA7 | P43166 | 7/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 7/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | APEX1 | P27695 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5353740 | 0.85 | G6PD (0.56) | CA2CA1CA12CA9CA4 | |
| SCHEMBL10064161 | 0.85 | KDM4E (0.66) | CA2CA1CA12CA9CA4 | |
| SCHEMBL4953803 | 0.82 | HTR6 (0.67) | CA2CA1CA12CA9CA4 | |
| SCHEMBL1806178 | 0.82 | CA2 (0.63) | CA2CA1CA12CA9CA4 | |
| SCHEMBL29828429 | 0.81 | PKM (0.87) | CA2CA1CA12CA9CA4 | |
| SCHEMBL1911572 | 0.81 | PKM (0.87) | CA2CA1CA12CA9CA4 | |
| SCHEMBL393315 | 0.79 | CA2 (0.54) | CA2CA1CA12CA9CA4 | |
| SCHEMBL31095544 | 0.79 | CA2 (0.54) | CA2CA1CA12CA9CA4 | |
| SCHEMBL7954618 | 0.78 | CA1 (0.53) | CA2CA1CA12CA9CA4 | |
| SCHEMBL1809177 | 0.78 | CA2 (0.53) | CA2CA1CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114471426-B | Refined sulfonamide integrated preparation system | 济宁正东化工有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20220202835-A1 | INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-06-30 | — | — | US | disclosed |
| CN-114471426-A | Fine sulfanilamide integrated preparation system | 济宁正东化工有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113507922-A | Injectable clorsulon compositions, methods and uses thereof | 勃林格殷格翰动物保健美国公司 | 2021-10-15 | — | — | CN | disclosed |
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
| US-7781613-B2 | Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments | SANOFI-AVENTIS (FR) | 2010-08-24 | — | — | US | disclosed |
| US-20080069851-A1 | SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
| US-7235548-B2 | Compounds and their use as positive AMPA receptor modulators | NEUROSEARCH A/S (DK) | 2007-06-26 | — | — | US | disclosed |
| US-6943159-B1 | Compounds and their use as positive AMPA receptor modulators | NEUROSEARCH A/S (DK) | 2005-09-13 | — | — | US | disclosed |
| US-20040043987-A1 | Novel compounds and their use as positive AMPA receptor modulators | NEUROSEARCH A/S. | 2004-03-04 | — | — | US | disclosed |
| EP-1071426-A2 | NOVEL COMPOUNDS AND THEIR USE AS POSITIVE AMPA RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2001-01-31 | — | — | EP | disclosed |
| WO-1999042456-A2 | NOVEL COMPOUNDS AND THEIR USE AS POSITIVE AMPA RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 1999-08-26 | — | — | WO | disclosed |
| US-4064239-A | LIVER FLUKES | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
| US-4062952-A | Substituted benzenedisulfonamides as anthelmintics | MERCK & CO., INC. (US) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202835-A1 | INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF | IL5, IL17A, IL33 | CA2 1585/4885CA1 916/4885CA12 613/4885 |
| US-20040043987-A1 | Novel compounds and their use as positive AMPA receptor modulators | GRIK4, GRIA4, GRM2 | CA2 365/4885CA1 388/4885CA12 1624/4885 |
| US-20080069851-A1 | SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | LIPE, STS, ARSA | CA2 2004/4885CA1 3065/4885CA12 2840/4885 |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | CA2 1279/4885CA1 798/4885CA12 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.